Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TARIQ AHMAD

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1104955699
CMS profile
1220506
Location
NEW HAVEN, CT

General Payments · PY2018–2024

$74,386.40

  • Reported across 67 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$41,851.82

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $12,843.11 6
Eli Lilly and Company $11,810.00 7
Edwards Lifesciences Corporation $10,464.12 2
Lilly USA, LLC $3,600.00 1
AstraZeneca UK Limited $1,611.00 1
Boehringer Ingelheim Pharmaceuticals, Inc. $1,362.49 10
Abbott Laboratories $131.44 1
HEARTFLOW, INC. $29.66 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,415.15 14
PY2019 $7,123.12 13
PY2020 $11,630.41 4
PY2021 $273.64 1
PY2022 $4,423.78 2
PY2023 $1,668.48 4
PY2024 $41,851.82 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $131.44 04/23/2024 Food and Beverage Undisputed 01/23/2026 1124849354 CMS
AstraZeneca UK Limited $1,611.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 1094049618 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $506.49 03/15/2024 Travel and Lodging Undisputed 01/23/2026 1117875879 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $249.32 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1117875877 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $118.72 04/08/2024 Food and Beverage Undisputed 01/23/2026 1117875873 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $37.40 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117875861 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $37.40 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117875863 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $46.74 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117875865 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $46.74 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117875867 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $160.29 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1117875875 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $56.13 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1117875869 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $103.26 08/13/2024 Food and Beverage Undisputed 01/23/2026 1117875871 CMS
Edwards Lifesciences Corporation $864.12 01/22/2024 Travel and Lodging Undisputed 01/23/2026 1138794780 CMS
Edwards Lifesciences Corporation $9,600.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1138794822 CMS
Eli Lilly and Company $5,400.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 1135425727 CMS
Eli Lilly and Company $2,100.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 1135478314 CMS
Eli Lilly and Company $18.00 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135425729 CMS
Eli Lilly and Company $25.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135448663 CMS
Eli Lilly and Company $67.00 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135478316 CMS
Eli Lilly and Company $1,800.00 11/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135455317 CMS
Eli Lilly and Company $2,400.00 12/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135425725 CMS
HEARTFLOW, INC. $29.66 03/20/2024 Food and Beverage Undisputed 01/23/2026 1154169124 CMS
Lilly USA, LLC $3,600.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1135455319 CMS
Novo Nordisk Inc $46.54 09/06/2024 Food and Beverage Undisputed 01/23/2026 1096899094 CMS
Novo Nordisk Inc $775.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1096877255 CMS
Novo Nordisk Inc $10,268.75 12/05/2024 Consulting Fee Undisputed 01/23/2026 1096633652 CMS
Novo Nordisk Inc $1,351.50 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1096988679 CMS
Novo Nordisk Inc $189.26 12/05/2024 Food and Beverage Undisputed 01/23/2026 1097496576 CMS
Novo Nordisk Inc $212.06 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1097693617 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.